Gene Network Sciences to Analyze Biomarker Data for Biogen Idec | GenomeWeb
NEW YORK (GenomeWeb News) – Gene Network Sciences will process clinical data from Biogen Idec to identify targets and biomarkers for inflammation, GNS said today.
 
GNS will use the data to develop a forward-simulation model that Biogen will then license.
 
GNS uses massively parallel supercomputers to search through “vast amounts of raw human biological data” for causes of disease and information about disease treatment, the company said.
 

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

In Nature this week: genome-wide transcriptome analysis of brain samples from people with autism spectrum disorder, flounder genome, and more.

Researchers used T-cell transfer therapy to target mutation KRAS, according to the New York Times.

The US Senate has passed the 21st Century Cures Act, which would provide a funding boost at NIH while overhauling FDA policies.

Bloomberg reports that President-elect Donald Trump is considering Jim O'Neill for Food and Drug Administration commissioner.